|
|
|
|
Vol. 10, Issue 12, 4231-4246, December 1999
and
*Department of Radiation Oncology, Medical College of Virginia,
Virginia Commonwealth University, Richmond, Virginia 23298; and
We investigated the role of the cdk inhibitor protein
p21Cip-1/WAF1/MDA6 (p21) in the ability of MAPK pathway
inhibition to enhance radiation-induced apoptosis in A431 squamous
carcinoma cells. In carcinoma cells, ionizing radiation (2 Gy) caused
both primary (0-10 min) and secondary (90-240 min) activations of the
MAPK pathway. Radiation induced p21 protein expression in A431 cells
within 6 h via secondary activation of the MAPK pathway. Within
6 h, radiation weakly enhanced the proportion of cells in
G1 that were p21 and MAPK dependent, whereas the elevation
of cells present in G2/M at this time was independent of
either p21 expression or MAPK inhibition. Inhibition of the MAPK
pathway increased the proportion of irradiated cells in
G2/M phase 24-48 h after irradiation and enhanced
radiation-induced apoptosis. This correlated with elevated Cdc2
tyrosine 15 phosphorylation, decreased Cdc2 activity, and decreased
Cdc25C protein levels. Caffeine treatment or removal of MEK1/2
inhibitors from cells 6 h after irradiation reduced the proportion
of cells present in G2/M phase at 24 h and abolished
the ability of MAPK inhibition to potentiate radiation-induced
apoptosis. These data argue that MAPK signaling plays an important role
in the progression/release of cells through G2/M phase
after radiation exposure and that an impairment of this
progression/release enhances radiation-induced apoptosis. Surprisingly,
the ability of irradiation/MAPK inhibition to increase the proportion
of cells in G2/M at 24 h was found to be dependent on
basal p21 expression. Transient inhibition of basal p21 expression
increased the control level of apoptosis as well as the abilities of
both radiation and MEK1/2 inhibitors to cause apoptosis. In addition,
loss of basal p21 expression significantly reduced the capacity of MAPK
inhibition to potentiate radiation-induced apoptosis. Collectively, our
data argue that MAPK signaling and p21 can regulate cell cycle
checkpoint control in carcinoma cells at the G1/S
transition shortly after exposure to radiation. In contrast, inhibition
of MAPK increases the proportion of irradiated cells in
G2/M, and basal expression of p21 is required to maintain
this effect. Our data suggest that basal and radiation-stimulated p21
may play different roles in regulating cell cycle progression that
affect cell survival after radiation exposure.
Department of Urology and Pathology, Columbia University
College of Physicians and Surgeons, New York, New York 10032
Corresponding author. E-mail address:
pdent{at}hsc.vcu.edu.
This article has been cited by other articles:
![]() |
R. W. Caron, A. Yacoub, X. Zhu, C. Mitchell, S. I. Han, T. Sasazuki, S. Shirasawa, M. P. Hagan, S. Grant, and P. Dent H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent Mol. Cancer Ther., February 1, 2005; 4(2): 243 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Caron, A. Yacoub, M. Li, X. Zhu, C. Mitchell, Y. Hong, W. Hawkins, T. Sasazuki, S. Shirasawa, A. P. Kozikowski, et al. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival Mol. Cancer Ther., February 1, 2005; 4(2): 257 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Raben, B. Helfrich, D. C. Chan, F. Ciardiello, L. Zhao, W. Franklin, A. E. Baron, C. Zeng, T. K. Johnson, and P. A. Bunn Jr The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer Clin. Cancer Res., January 15, 2005; 11(2): 795 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dai, C. Yu, V. Singh, L. Tang, Z. Wang, R. McInistry, P. Dent, and S. Grant Pharmacological Inhibitors of the Mitogen-activated Protein Kinase (MAPK) Kinase/MAPK Cascade Interact Synergistically with UCN-01 to Induce Mitochondrial Dysfunction and Apoptosis in Human Leukemia Cells Cancer Res., July 1, 2001; 61(13): 5106 - 5115. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lammering, T. H. Hewit, W. T. Hawkins, J. N. Contessa, D. B. Reardon, P.-S. Lin, K. Valerie, P. Dent, R. B. Mikkelsen, and R. K. Schmidt-Ullrich Epidermal Growth Factor Receptor as a Genetic Therapy Target for Carcinoma Cell Radiosensitization J Natl Cancer Inst, June 20, 2001; 93(12): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Park, L. Qiao, D. Gilfor, M. Y. Yang, P. B. Hylemon, C. Benz, G. Darlington, G. Firestone, P. B. Fisher, and P. Dent A Role for Both Ets and C/EBP Transcription Factors and mRNA Stabilization in the MAPK-dependent Increase in p21 Cip-1/WAF1/mda6 Protein Levels in Primary Hepatocytes Mol. Biol. Cell, September 1, 2000; 11(9): 2915 - 2932. [Abstract] [Full Text] |
||||